Brief: Chemomab Therapeutics Discloses Receipt Of Nasdaq Notice Regarding Minimum Bid Price Requirement
06/11/2023 21:49
Nov 6 (Reuters) - Chemomab Therapeutics Ltd CMMB.O :
* CHEMOMAB THERAPEUTICS DISCLOSES RECEIPT OF NASDAQ NOTICE
REGARDING MINIMUM BID PRICE REQUIREMENT
Source text for Eikon: ID:nPnbm3Dd7a
Further company coverage: CMMB.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Chemomab Therapeutics
See all newsBrief: Chemomab Therapeutics Announces Second Quarter 2026 Financial Results And Provides Corporate Update
Chemomab Therapeutics Ltd expected to post a loss of 15 cents a share - Earnings Preview
Israel's Chemomab Q4 net loss narrows on lower R&D spend
Brief: Chemomab Therapeutics Announces Nebokitug Phase 2 Spring Trial Results
Brief: Chemomab Therapeutics Announces Third Quarter 2025 Financial Results And Provides Corporate Update